Is Pseudomyxoma Peritonei hereditary?

Pseudomyxoma peritonei (PMP) is generally not considered an inherited or hereditary condition, meaning it is not passed down through families in a predictable genetic pattern. While most cases arise sporadically, researchers continue to study the molecular origins of the underlying primary tumors that lead to the development of Pseudomyxoma peritonei.

Is Pseudomyxoma peritonei hereditary?

In the vast majority of cases, Pseudomyxoma peritonei is not an inherited disease. It is typically classified as a sporadic condition, meaning it occurs by chance due to somatic mutations (changes in DNA that happen after conception) within the cells of the appendix or other abdominal organs. Because these mutations are not present in the germline (the egg or sperm), they are not passed to children.

Are there genetic factors involved in Pseudomyxoma peritonei?

While Pseudomyxoma peritonei is not inherited, it is a disease of genetic change. The condition is characterized by the slow growth of mucinous tumors, often originating from a low-grade appendiceal mucinous neoplasm (LAMN). Genetic researchers have identified several mutations frequently associated with these tumors:

• GNAS mutations: Found in a high percentage of patients with Pseudomyxoma peritonei.


• KRAS mutations: Often co-occur with GNAS, driving the proliferation of mucin-producing cells.


• RNF43 mutations: Sometimes identified in studies of these specific tumor types.

Is genetic testing recommended for families?

Because Pseudomyxoma peritonei is not hereditary, routine genetic testing for family members is not standard clinical practice. Genetic counseling is generally only recommended if a patient has a strong family history of multiple cancers, which might suggest a hereditary cancer syndrome (such as Lynch Syndrome or Peutz-Jeghers syndrome) that could predispose an individual to appendiceal tumors. If you are concerned about your family history, consulting a genetic counselor can help clarify whether your diagnosis is an isolated event or part of a broader, rare hereditary syndrome.

Are de novo mutations common?

The term "de novo" usually refers to germline mutations occurring for the first time in an individual. In Pseudomyxoma peritonei, the mutations are somatic, meaning they are "acquired" during the patient's lifetime. These are not spontaneous germline events, but rather somatic "hits" that occur in specific cells, leading to the development of the primary tumor that eventually causes Pseudomyxoma peritonei.

Next steps

• Consult with a surgical oncologist who specializes in cytoreductive surgery and HIPEC.


• Discuss your family history with your physician to rule out hereditary cancer syndromes.


• Join the 110 members on DiseaseMaps.org to share experiences and find support within our community.


• Monitor for symptoms like abdominal swelling or persistent changes in bowel habits.

Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment.

References

• NIH Genetic and Rare Diseases Information Center (GARD)


• Orphanet: Portal for rare diseases and orphan drugs


• OMIM (Online Mendelian Inheritance in Man)


• PMP Pals (Patient-led advocacy group for Pseudomyxoma peritonei)